The financing was led by Three Arch Partners and joined by additional new investors InterWest Partners and Pinnacle Ventures. Existing investors Charter Life Sciences, Great Point Partners, Versant
Takeda is the originator of the thiazolidinedione (TZD) class of oral anti-diabetic medications. Actos is a member of TZDs that help reduce insulin resistance, which is one of
Alogliptin is a dipeptidyl peptidase-IV inhibitor taken once a day, and was created by Takeda San Diego, Takeda’s wholly-owned subsidiary located in San Diego, California. Large-scale clinical studies
Under the terms of the agreement, Bharat Serums and Vaccines (BSV) will develop and manufacture the product for marketing by Actavis in Europe, Australia, South Africa and Turkey.
Partners at the University of Washington’s Center for Industrial and Medical Ultrasound, the Texas A&M University’s Institute for Preclinical Studies and Siemens Corporate Research (SCR) will work together
Mr Benton will succeed William Claypool, who is leaving Phoenix Data Systems to start a pharmaceutical development consulting company, Pennmark Associates. Most recently, Mr Benton was COO of
As part of this plan, Vertellus is proceeding with the engineering and permitting work to build a 3-cyanopyridine production unit at Nantong with capacity of 7,000 metric tons
Frank DiCosmo, president and CEO of Covalon, said: “Peter has significant experience in the medical devices industry, having previously served as director of finance for Stryker Canada. “Peter
Ms Mullarky has joined Tekmira effective immediately and will have responsibility for strategic planning and business development including securing additional licensing and collaborative R&D agreements for Tekmira’s technology.
The company has achieved its primary clinical endpoint for the trial, autograft engraftment comparable to the standard of care. No adverse or serious adverse events were deemed to
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.